Clinical Trials Sponsored by Anup Kasi

Total 499 results

Anup Kasi
Cend Therapeutics Inc.

Recruiting

CEND-1 in Combination With Neoadjuvant FOLFIRINOX With or Without Panitumumab (CENDIFOX)

Colon Cancer | Pancreas Cancer | Digestive Cancer

United States
Anup Katheria, M.D.

Completed

Short-Delay Cord Clamping Compared to Extended- Delay Cord Clamping in Term Neonates That Require Resuscitation. (Term-NRIC)

Placental Transfusion

United States
Madunil Anuk Niriella

Active, not recruiting

Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease

Sri Lanka
Fresenius Kabi Japan

Completed

Study to Obtain Volume Effect and Safety Data on 6 % Hydroxyethyl Starch 130/0.4 in Pediatric and Adult Patients Undergoing Major Elective Surgery

Plasma Volume Substitution (Hypovolemia) Including Massive Hemorrhage

Japan
Fresenius Kabi Japan

Completed

Trial of 6% HES130/0.4

Hemorrhage | Hypovolemia

Japan
Anu Sharma

Terminated

Propranolol in Treating Hypoglycemia Unawareness

Type 1 Diabetes Mellitus

United States
Mayo Clinic
ARUP Laboratories; Eastern Mennonite Missions

Completed

Pharmacokinetics of Thiamine in Breastfeeding Mothers and Infants

Beriberi

United States, Cambodia
Fresenius Kabi

Completed

A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response (OPALE)

Rheumatoid Arthritis | Psoriasis | Crohn Disease | Ulcerative Colitis | Psoriatic Arthritis | Ankylosing Spondylitis

France
Fresenius Kabi

Withdrawn

Safety of Omegaven in Pediatric Patients With Parenteral Nutrition-Associated Cholestasis (PNAC)

Malnutrition | Pediatric ALL | Neurocognitive Deficit | Parenteral Nutrition Associated Liver Disease | Essential Fatty Acid Deficiency
Fresenius Kabi

Terminated

Efficacy Study of Long-term Parenteral Nutrition With SmofKabiven® E in Lung Cancer Patients Under Anticancer Therapy

Cancer-related Malnutrition

France
Fresenius Kabi

Completed

Observational Study on Chronic Kidney Disease Treatment With a Ketosteril Supplemented Protein-restricted Diet

Chronic Kidney Disease

Hungary
Fresenius Kabi

Completed

Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers

Blood Glucose

Germany
Fresenius Kabi

Completed

Screening Day Latin America

Malnutrition | Nutritional Status | Caloric Deficit

Colombia, Brazil, Mexico, Ecuador, Peru, Chile, Argentina, Panama
Fresenius Kabi

Terminated

Fluid Resuscitation in Patients Suffering From Burns Injury

Burns

United Kingdom
Fresenius Kabi

Completed

Safety, Acceptability and Efficacy of a Long-term Intervention With a Diabetes-specific Low-carbohydrate, High-mono-unsaturated Fatty Acid Containing Oral Nutritional Supplement on Glycaemic Control in Type 2 Diabetic Patients

Diabetes

Germany
Fresenius Kabi

Completed

Voluven® in Paediatric Patients

Cardiac Surgery | Cardiopulmonary Bypass

Austria, Belgium
Fresenius Kabi

Terminated

Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Lung Cancer Patients

Cancer | Cachexia

Italy, Poland
Fresenius Kabi

Completed

The Effect of a New Specific Enteral Formula Compared to a Standard Formula on the Tolerability of a Combined Radio- and Chemotherapy in Cancer Patients

Enteral Nutrition

Germany
Fresenius Kabi

Terminated

Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation

Intraoperative Complications

China
Fresenius Kabi

Completed

Preoperative Oral Nutritional Supplement (preOP Booster) in Visceral Surgery

Enteral Nutrition (Food for Special Medical Purposes)

Italy
Fresenius Kabi

Completed

Study to Evaluate the Effect of Hydroxyethyl Starch (HES) in Complications of Patients After Abdominal Surgery

Postoperative Complications

China
Fresenius Kabi

Not yet recruiting

bIosimilar of aDalimumab, an European evAluation (IDEA)

Rheumatoid Arthritis | Crohn Disease | Ulcerative Colitis | Psoriatic Arthritis | Ankylosing Spondylitis
Fresenius Kabi

Completed

Chronic Kidney Disease Observational Database - Taiwan (CKDOD)

Chronic Kidney Insufficiency

Taiwan
Fresenius Kabi

Terminated

Phase 3 Study to Compare Safety and Efficacy of Smoflipid 20% to Intralipid 20% in Hospitalized Neonates and Infants

Hospitalized Neonates and Infants, Expected to Require Parenteral Nutrition for 28 Days

United States
Fresenius Kabi

Terminated

Reaching Protein Target With SmofKabiven® Extra Nitrogen vs Olimel N9E During the Early Phase of Acute Critical Illness

Critical Illness

France, Germany, Poland
Fresenius Kabi

Completed

Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-027-CNI)

Chronic Kidney Disease

Russian Federation
Fresenius Kabi

Completed

Safety, Tolerance and Efficacy of an Oral Nutritional Supplement in Chronic Heart Failure and Chronic Obstructive Pulmonary Disease Patients

Chronic Obstructive Pulmonary Disease | Chronic Heart Failure | Cachexia

Germany, Poland
Fresenius Kabi

Completed

Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Scheduled Intake

Malnutrition

Germany
Fresenius Kabi

Completed

Tolerance and Compliance of a High Caloric, High Protein Oral Nutritional Supplement - Free Intake

Malnutrition

Germany
Fresenius Kabi

Completed

Efficacy of Voluven® for the Prevention of Hypotension During Spinal Anesthesia for Cesarean Section (CAESAR)

Hypotension

France
Fresenius Kabi

Completed

Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition

Parenteral Nutrition

Australia, Denmark, France, Israel, Netherlands, Poland, United Kingdom
Fresenius Kabi

Completed

Gastric Emptying Study After Administration of a High Caloric Sip Feed

Enteral Nutrition

Germany
Fresenius Kabi

Not yet recruiting

Safety Study to Evaluate the Occurrence of EFAD in Pediatric Patients With PNAC Who Require More Than Eight Weeks of Omegaven Treatment

Malnutrition | Pediatric ALL | Essential Fatty Acid Deficiency | Parenteral Nutrition Associated Liver Disease (PNALD)
Fresenius Kabi

Not yet recruiting

Safety Study of SMOFlipid to Evaluate the Risk of Developing EFAD and/or PNAC in Pediatric and Adult Patients

Malnutrition | Malnutrition, Child

United States
Fresenius Kabi

Completed

Efficacy and Safety of SmofKabiven Extra Nitrogen for Parenteral Nutrition in Patients Receiving Intensive Care

Critical Illness | Nutrition Therapy

Russian Federation
Fresenius Kabi

Terminated

Safety and Efficacy Study to Compare Smoflipid and Intralipid 20% in Pediatric Patients of 3 Months to 16 Years of Age

Malnutrition, Child

United States
Fresenius Kabi

Terminated

Quality of Care of Oncological Patients With HPN (VHPE-S)

Tumors and Home Parenteral Nutrition

Germany
Fresenius Kabi

Completed

Three-Chamber Bags Retrospective Study in Spain

Parenteral Nutrition | Blood Stream Infection

Spain
Fresenius Kabi

Withdrawn

Study to Assess Safety and Efficacy of Kabiven® in Pediatric Patients 2 to 16 Years of Age

Malnutrition

United States
Fresenius Kabi

Completed

Blood Glucose Response After Oral Intake of Lactulose in Mildly Constipated Patients With Diabetes Mellitus Type 2

Diabetes Mellitus, Type 2

Austria
Fresenius Kabi

Completed

Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)

Chronic Kidney Disease

China
Fresenius Kabi

Completed

Bioequivalence Study of Fulvestrant Injection 50 mg/mL in Healthy Post-menopausal Female Subjects

Healthy

Canada
Fresenius Kabi

Completed

VolulyteTM in Cardiac Surgery

Heart; Dysfunction Postoperative, Cardiac Surgery

Canada
Fresenius Kabi

Completed

Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe Sepsis (CRYSTMAS)

Sepsis

France, Germany
Fresenius Kabi

Completed

Controlled Study to Evaluate Efficacy and Safety of α-KA Tab With Low Protein Diet (LPD) in Delaying the Progress of Type 2 Diabetic Nephropathy (DN)

Diabetic Nephropathy

China
Fresenius Kabi

Completed

Effectiveness and Tolerability of an Oral Nutritional Supplement (PreOP Booster) Given Before Surgery

Rectal Tumors

Netherlands
Fresenius Kabi

Completed

Study on Safety, Tolerance and Metabolic Effects of a Nutritional Supplement, Given as a Drink Before Gallbladder Surgery

Enteral Nutrition Regimen Prior to Surgery

United Kingdom
Clarus Therapeutics, Inc.
Celerion; Syneos Health; ARUP Laboratories

Completed

Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes

Hypogonadism, Male

United States
Fresenius Kabi, France

Recruiting

Assessment of Predictive Factors for Persistence of Treatment After Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases (SAPHIR)

Rheumatoid Arthritis | Crohn Disease | Ulcerative Colitis | Psoriatic Arthritis | Ankylosing Spondylitis

France
CASI Pharmaceuticals, Inc.

Active, not recruiting

CID-103 (Anti-CD38 Antibody) in Previously Treated Relapsed or Refractory Multiple Myeloma

Multiple Myeloma

United Kingdom, France

3

Subscribe